Longaeva Partners’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7M Buy
+71,122
New +$7.66M 0.28% 89

Other funds holding MRNA

Longaeva Partners's MRNA Position: Q3 2026 in Review

Longaeva Partners opened a new position in Moderna (MRNA) in Q3 2026: 71,122 shares worth $13.7M. The stake represents 0.28% of the portfolio and ranks #89 among its holdings.

1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Longaeva Partners held 71,122 shares of Moderna worth $13.7M as of Q3 2026.
  • Moderna was a new Longaeva Partners position in Q3 2026.
  • Moderna made up 0.28% of Longaeva Partners's portfolio in Q3 2026, its #89 holding.
  • 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.